Express News | IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (Asgct) 2024 Annual Meeting
Moomoo 24/7Apr 24 08:00 ET
IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced an oral presen
In8bioApr 24 00:00 ET
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced that William H
In8bioApr 16 00:00 ET
12 Health Care Stocks Moving In Friday's After-Market Session
GainersQilian Intl Hldg Gr (NASDAQ:QLI) stock moved upwards by 50.4% to $1.14 during Friday's after-market session. The company's market cap stands at $40.7 million. Allarity Therapeutics (NASDAQ:ALLR
BenzingaApr 12 16:31 ET
Promising Preclinical Data Underpins Buy Rating for IN8bio's NsCAR Platform
TipRanksApr 12 01:45 ET
ATUS, ATHE and GRFS Among Pre-market Losers
Seeking AlphaApr 11 08:16 ET
HC Wainwright & Co. Reiterates Buy on IN8bio, Maintains $14 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates IN8bio with a Buy and maintains $14 price target.
Analyst UpgradesApr 10 10:51 ET
Analysts Offer Insights on Healthcare Companies: TRACON Pharmaceuticals (TCON) and IN8bio (INAB)
TipRanksApr 10 10:20 ET
IN8bio Gains After New Preclinical Data for NsCAR-T Cell Therapy Platform
Seeking AlphaApr 10 09:49 ET
IN8bio INAB Preclinical Data; Jaguar JAGX Shareholder Meeting
BioPharmCatalystApr 10 08:24 ET
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Shares of PriceSmart, Inc. (NASDAQ:PSMT) rose sharply in today's pre-market trading as the company posted better-than-expected earnings for its second quarter. The company reported quarterly earnings
BenzingaApr 10 08:12 ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersIN8bio (NASDAQ:INAB) stock increased by 47.7% to $1.61 during Wednesday's pre-market session. The market value of their outstanding shares is at $69.6 million. Jaguar Health (NASDAQ:JAGX) share
BenzingaApr 10 08:09 ET
Top Premarket Gainers
Marin Software (MRIN) shares surged 58% in recent Wednesday premarket activity a day after it upgraded its integration with Microsoft (MSFT) Advertising. Jaguar Health (JAGX) stock rose over 34% a day
MT NewswiresApr 10 07:54 ET
Express News | IN8bio Shares Are Trading Higher After the Company Announced New Preclinical Data for INB-300
Moomoo 24/7Apr 10 07:26 ET
IN8bio Shares Pop 32% on Early Cancer Treatment Data
By Ben Glickman Shares of IN8bio rose in late trading after the company said early data on its potential cancer treatment suggested it may be able to avoid killing healthy cells. The stock was up 32
WSJApr 9 19:09 ET
IN8bio Announces New Preclinical Data for Gamma-Delta NsCAR-T Cell Therapy Platform at AACR 2024
IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced new preclinical data from its non-signaling gamma-delta T cell based Chimeric Antigen Receptor-T cell (nsCAR) platform, known as INB-300, that demonstrated improved selectivity to target leukemia cells while preserving healthy ones.
InvestingApr 9 16:42 ET
Express News | IN8bio Shares Are Trading Higher After the Company Announced New Preclinical Data From Its Non-signaling Gamma-delta T Cell Based Chimeric Antigen Receptor-T Cell Platform
Moomoo 24/7Apr 9 16:40 ET
Express News | IN8bio Announces Presentation Of New Preclinical Data For Gamma-Delta NsCAR-T Cell Therapy Platform At AACR 2024; Says 'Preclinical Data Supports Potential for Proprietary NsCAR Platform to Selectively Eliminate Cancer Cells While Preserving Healthy Tissu
Moomoo 24/7Apr 9 16:31 ET
We're Keeping An Eye On IN8bio's (NASDAQ:INAB) Cash Burn Rate
Yahoo FinanceMar 28 09:15 ET
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Intuitive Surgical (ISRG) and IN8bio (INAB)
TipRanksMar 19 02:21 ET
No Data
No Data